日
Menu

© Laboratory of Proteomics for Drug Discovery, Center for Drug Design Research, National Institutes of Biomedical Innovation, Health and Nutrition

Publications

2011

  1. Abulaizi M., Tomonaga T., Satoh M., Sogawa K., Matsushita K., Kodera Y., Obul J., Takano S., Yoshitomi H., Miyazaki M., Nomura F. The Application of a Three-Step Proteome Analysis for Identification of New Biomarkers of Pancreatic Cancer. Int J Proteomics. 2011:628787. DOI: 10.1155/2011/628787
  2. Wu D., Matsushita K., Matsubara H., Nomura F., Tomonaga T. An alternative splicing isoform of eukaryotic initiation factor 4H promotes tumorigenesis in vivo and is a potential therapeutic target for human cancer. Int J Cancer 2011;128:1018-30. DOI: 10.1002/ijc.25419
  3. Tonoike Y., Matsushita K., Tomonaga T., Katada K., Tanaka N., Shimada H., Nakatani, Y., Okamoto, Y., Nomura, F. Adhesion molecule periplakin is involved in cellular movement and attachment in pharyngeal squamous cancer cells. BMC Cell Biol 2011;12:41. DOI: 10.1186/1471-2121-12-41. 
  4. Sogawa K., Kodera Y., Noda K., Ishizuka Y., Yamada M., Umemura H., Maruyama, K., Tomonaga, T., Yokosuka, O., Nomura, F. The measurement of a fibrinogen alpha C-chain 5.9kDa fragment (FIC 5.9) using MALDI-TOF MS and a stable isotope-labeled peptide standard dilution. Clin Chim Acta 2011;412:1094-9. DOI: 10.1016/j.cca.2011.02.029
  5. Muto T., Taniguchi H., Kushima R., Tsuda H., Yonemori H., Chen C., Sugihara, Y., Sakamoto, K., Kobori, Y., Palmer, H., Nakamura, Y., Tomonaga, T., Tanaka, H., Mizushima, H., Fujita, S., Kondo, T. Global expression study in colorectal cancer on proteins with alkaline isoelectric point by two-dimensional difference gel electrophoresis. J Proteomics 2011;74:858-73. DOI: 10.1016/j.jprot.2011.02.030
  6. Kitamura A., Matsushita K., Takiguchi Y., Shimada H., Tada Y., Yamanaka M., Hiroshima K., Tagawa M., Tomonaga T., Matsubara H., Inoue M., Hasegawa M., Sato Y., Levens D., Tatsumi K., Nomura F. Synergistic effect of non-transmissible Sendai virus vector encoding the c-myc suppressor FUSE-binding protein-interacting repressor plus cisplatin in treatment of malignant pleural mesothelioma. Cancer Sci. 2011;102:1366-73. DOI: 10.1111/j.1349-7006.2011.01931.x
  7. Hagiwara T., Saito Y., Nakamura Y., Tomonaga T., Murakami Y., Kondo T. Combined use of a solid-phase hexapeptide ligand library with liquid chromatography and two-dimensional difference gel electrophoresis for intact plasma proteomics. Int J Proteomics. 2011;2011:739615. DOI: 10.1155/2011/739615
  8. Singh CR., Watanabe R., Zhou Donghui., Jennings MD., Fukao A., Lee B., Ikeda Y., Chiorini JA., Campbell SG., Fujiwara T., Ashe MP., Wek RC., Pavitt GD., Asano K. Mechanisms of translational regulation by a human eIF5 mimic protein. Nucleic Acids Research 2011; 19: 8314-28. DOI: 10.1093/nar/gkr339
  9. Watanabe R., Wei L., Huang J. mTOR signaling, function, novel inhibitors, and therapeutic targets.　Journal of Nuclear Medicine 2011; 4: 497-500. DOI: 10.2967/jnumed.111.089623